These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9458305)

  • 1. Medroxyprogesterone acetate and megestrol acetate reduce cisplatin-induced serotonin release from human peripheral blood mononuclear cells of cancer patients.
    Mantovani G; Macciò A; Lai P; Esu S; Massa E; Santona MC; Massa D; Dessì D; Ghiani M
    Oncol Rep; 1998; 5(1):121-4. PubMed ID: 9458305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms.
    Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC
    Crit Rev Oncog; 1998; 9(2):99-106. PubMed ID: 9973244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate.
    Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):45-52. PubMed ID: 9625383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients.
    Mantovani G; Macciò A; Esu S; Lai P; Santona MC; Massa E; Dessì D; Melis GB; Del Giacco GS
    Eur J Cancer; 1997 Apr; 33(4):602-7. PubMed ID: 9274442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancer.
    Willemse PH; van der Ploeg E; Sleijfer DT; Tjabbes T; van Veelen H
    Eur J Cancer; 1990 Mar; 26(3):337-43. PubMed ID: 2141491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that cisplatin induces serotonin release from human peripheral blood mononuclear cells and that methylprednisolone inhibits this effect.
    Mantovani G; Macciò A; Esu S; Lai P
    Eur J Cancer; 1996 Oct; 32A(11):1983-5. PubMed ID: 8943685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of medroxyprogesterone acetate and megesterol acetate during long-term follow-up in patients treated for metastatic breast cancer.
    Miller AA; Becher R; Schmidt CG
    J Cancer Res Clin Oncol; 1988; 114(2):186-90. PubMed ID: 2965155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal steroids as parameters of the bioavailability of MA and MPA.
    Willemse PH; Dikkeschei LD; Tjabbes T; van Veelen H; Sleijfer DT
    Eur J Cancer; 1990 Mar; 26(3):359-62. PubMed ID: 2141494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer.
    Lundgren S; Lønning PE; Aakvaag A; Kvinnsland S
    Cancer Chemother Pharmacol; 1990; 27(2):101-5. PubMed ID: 2249324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in-vitro effects of medroxyprogesterone acetate on acidic pH induced apoptosis of periferal blood mononuclear cells.
    Ozdemir F; Ovali E; Aydin F; Kavgaci H; Büyükcelik A; Ucar F; Sönmez M
    J Exp Clin Cancer Res; 2004 Mar; 23(1):93-5. PubMed ID: 15149156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin induces serotonin release from human peripheral blood mononuclear cells of cancer patients and methylprednisolone inhibits this effect.
    Mantovani G; Maccio A; Massa E; Lai P; Esu S
    Oncol Rep; 1997; 4(5):1051-3. PubMed ID: 21590194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Megestrol acetate in various doses in the treatment of metastatic breast carcinoma--clinical and endocrinologic studies].
    Wander HE; Blossey HC; Nagel GA; Emrich D
    Klin Wochenschr; 1985 Apr; 63(7):312-8. PubMed ID: 2987601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medroxyprogesterone acetate increases HIV-1 infection of unstimulated peripheral blood mononuclear cells in vitro.
    Sampah ME; Laird GM; Blankson JN; Siliciano RF; Coleman JS
    AIDS; 2015 Jun; 29(10):1137-46. PubMed ID: 26035316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of advanced endometrial cancer].
    Okada H; Yamamoto T
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of progestins in the treatment of breast cancer.
    Blumenschein GR
    Semin Oncol; 1983 Dec; 10(4 Suppl 4):7-10. PubMed ID: 6230722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medroxyprogesterone acetate reduces the production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients.
    Mantovani G; Macciò A; Esu S; Lai P; Santona MC; Massa E; Dessì D; Melis G; Del Giacco S
    Biochem Soc Trans; 1997 May; 25(2):296S. PubMed ID: 9191340
    [No Abstract]   [Full Text] [Related]  

  • 17. Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levels.
    Maritz MF; Ray RM; Bick AJ; Tomasicchio M; Woodland JG; Govender Y; Avenant C; Hapgood JP
    PLoS One; 2018; 13(4):e0196043. PubMed ID: 29698514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers.
    Kouchaki B; Janbabai G; Alipour A; Ala S; Borhani S; Salehifar E
    Support Care Cancer; 2018 Jul; 26(7):2479-2489. PubMed ID: 29442239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestin as an alternative treatment option for multi-treated recurrent triple-negative breast cancer.
    Xiangying M; Shikai W; Zefei J; Bing S; Yan M; Xin Z; Lijuan D; Yue W; Tao W; Shaohua Z; Santai S
    Swiss Med Wkly; 2013; 143():w13765. PubMed ID: 23740185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of short-term administration of medroxyprogesterone acetate on side reactions of combination chemotherapy with ADR, VDS and CDDP in primary lung cancer].
    Suzuki K; Nogimura H; Wada H; Tomii M; Sugimura H; Horiguchi T; Kimura T; Harada Y
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):431-5. PubMed ID: 1825910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.